Layer 1

Serious shortage protocol for fluoxetine 10mg extended

The SSP for fluoxetine 10mg was originally due to expire on June 12.
The SSP for fluoxetine 10mg was originally due to expire on June 12.

The Department of Health and Social Care (DH) has extended the serious shortage protocol (SSP) for fluoxetine 10mg tablets until September 11.

The SSP, announced on March 12, was set to expire on June 12. However, the protocol has been extended and will now end on September 11, the Pharmaceutical Services Negotiating Committee (PSNC) said yesterday (June 2).

Under the protocol, pharmacists are able to supply fluoxetine 10mg capsules against prescriptions for fluoxetine 10mg tablets.

The SSP was “put in place to manage stock”, and to “try to ensure that fewer patients have to return to their prescriber”, the PSNC explained.

The SSP expiry date “may be brought forward or extended, and the content may be amended throughout this period,” so pharmacists should “ensure they are using the current version of an SSP before supplying an alternative product,” it added.

“The pharmacist must exercise their professional judgement to ensure the alternative product is suitable for the patient,” the PSNC said.

Will this SSP help you provide a better service to your patients?

Richard Binns, Primary care pharmacist

can anyone explain why this protocol hasnt been extended to clenil inhalers, valupak vit d and emerade pens?

surley this would be a no-brainer in terms of benefits to patients, pharmacies and gps?



Job of the week

Accreditation and Recognition Panel member positions
Home Based
On application